Literature DB >> 15349957

In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.

Beena Ashok1, Lise Arleth, Rex P Hjelm, Israel Rubinstein, Hayat Onyüksel.   

Abstract

Sterically stabilized micelles (SSM) composed of poly(ethylene glycol-2000)-grafted distearoylphosphatidylethanolamine (DSPE-PEG) and sterically stabilized mixed micelles (SSMM) composed of DSPE-PEG and egg-phosphatidyl choline (PC) have recently been introduced as novel lipid based carriers for water-insoluble drugs. However, factors that affect the solubilization behavior of these phospholipid micelles are not well understood. This study investigates the effect of PEG chain length and PC content on physical properties and solubilization potential of PEGylated phospholipid micelles. Critical micelle concentrations (CMC) determined for DSPE-PEG with different PEG chain lengths (2000, 3000, and 5000) using a fluorescent probe were in the micromolar range (0.5-1.5 microM) with higher CMC for longer PEG chain length. The size of micelles determined by quasi-elastic light scattering (QELS) showed that micellar systems became heterogeneous when PC was added at > or =25% for DSPE-PEG 2000 and > or = 40% for DSPE-PEG 5000, respectively. Above these critical PC ratios a significant increase in aggregation number and formation of rodlike particles were observed by small angle neutron scattering (SANS). Solubilization of diazepam was greater with DSPE-PEG 2000 than DSPE-PEG 5000 simple micelles as determined by RP-HPLC. However, DSPE-PEG 5000 micelles showed greater improvement in solubilization of the water-insoluble drug with an increase in PC content. In conclusion, phospholipid micelle size and solubilization potential varied with PEG chain length and PC content in the mixed micelle. Aggregation number and shape of the micelles did not significantly change until the critical PC concentrations. Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15349957     DOI: 10.1002/jps.20150

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  68 in total

1.  Monocyte-targeting supramolecular micellar assemblies: a molecular diagnostic tool for atherosclerosis.

Authors:  Eun Ji Chung; Laurie B Mlinar; Kathryn Nord; Matthew J Sugimoto; Emily Wonder; Francis J Alenghat; Yun Fang; Matthew Tirrell
Journal:  Adv Healthc Mater       Date:  2014-08-22       Impact factor: 9.933

2.  The role of flexible tethers in multiple ligand-receptor bond formation between curved surfaces.

Authors:  Nathan W Moore; Tonya L Kuhl
Journal:  Biophys J       Date:  2006-06-02       Impact factor: 4.033

3.  Intracellular delivery of VIP-grafted sterically stabilized phospholipid mixed nanomicelles in human breast cancer cells.

Authors:  Israel Rubinstein; Imre Soos; Hayat Onyuksel
Journal:  Chem Biol Interact       Date:  2007-04-06       Impact factor: 5.192

4.  Development and characterization of lyophilized diazepam-loaded polymeric micelles.

Authors:  Jiraphong Suksiriworapong; Tanaporn Rungvimolsin; Atitaya A-gomol; Varaporn Buraphacheep Junyaprasert; Doungdaw Chantasart
Journal:  AAPS PharmSciTech       Date:  2013-10-03       Impact factor: 3.246

5.  VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer.

Authors:  Hayat Onyüksel; Prem S Mohanty; Israel Rubinstein
Journal:  Int J Pharm       Date:  2008-08-27       Impact factor: 5.875

6.  Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.

Authors:  Feihu Wang; Michael Porter; Alexandros Konstantopoulos; Pengcheng Zhang; Honggang Cui
Journal:  J Control Release       Date:  2017-09-25       Impact factor: 9.776

7.  Solubilization of therapeutic agents in micellar nanomedicines.

Authors:  Lela Vuković; Antonett Madriaga; Antonina Kuzmis; Amrita Banerjee; Alan Tang; Kevin Tao; Neil Shah; Petr Král; Hayat Onyuksel
Journal:  Langmuir       Date:  2013-12-09       Impact factor: 3.882

8.  Self-associated indisulam in phospholipid-based nanomicelles: a potential nanomedicine for cancer.

Authors:  Hacer Cesur; Israel Rubinstein; Ashwini Pai; Hayat Onyüksel
Journal:  Nanomedicine       Date:  2008-12-13       Impact factor: 5.307

9.  Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection.

Authors:  Bruna Dos Santos Rodrigues; Hiroshi Oue; Amrita Banerjee; Takahisa Kanekiyo; Jagdish Singh
Journal:  J Control Release       Date:  2018-07-31       Impact factor: 9.776

Review 10.  Nanomedicines in renal transplant rejection--focus on sirolimus.

Authors:  Li-Jiuan Shen; Fe-Lin Lin Wu
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.